Dendritic Cells (DC) Vaccine for Metastatic Melanoma

Clinical trial NCT01042366 · TERMINATED

Trial details

NCT number: NCT01042366
Sponsor: John Kirkwood
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2002-10-01
Primary completion: 2014-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.